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Introduction
Grayscale ultrasonography and color Doppler ultra-
sonography (CDU) are very useful tools for the evalua-
tion of abnormally adherent placentas. However, most
cases of placenta accreta were diagnosed in the second
and third trimesters of pregnancy. Recent studies have
reported the diagnosis of invasive placentation in the
first trimester. Shih et al [1] and Chen et al [2] reported
two cases of multipara with placenta increta/percreta,
wherein an emergency hysterectomy was performed at
15 weeks of gestation because of heavy antepartum
hemorrhage, with massive blood loss of 12,000 and
5,450 mL, respectively, during surgery. These two cases
showed that even though the diagnosis was made in
the first trimester and surgery was performed remote
from term, the surgical procedure might still be very
bloody and problematic. Therefore, it is clear that both
early antenatal diagnosis and an appropriate manage-
ment strategy are crucial for achieving a good outcome.
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SUMMARY
Objective: There is little prospective experience in the conservative treatment of placenta percreta during the
first trimester in order to preserve uterine fertility. We describe herein our experience with uterine artery
embolization (UAE) in the management of placenta percreta at 9 weeks of gestation.
Case Report: A 36-year-old woman, gravida 3, para 1, was referred for ultrasonographic evaluation because of
suspected molar pregnancy due to persistent vaginal spotting at 9 weeks of gestation. A Grade 3+ lacunar flow
pattern with multiple bizarre and large irregular sonolucent spaces were observed. Color Doppler imaging
revealed extensive turbulent lacunar blood flow perfusing throughout the whole surrounding uteroplacental 
tissues and fetus. The patient was informed of the situation and she had a strong desire to avoid surgery.
Conservative management with bilateral UAE was performed using polyvinyl alcohol particles to promote invo-
lution and shedding of the abnormally adherent placenta. However, an unsatisfactory vessel-occluding effect
caused by extensive collateral supply was still detected after repeated UAE. We, therefore, performed hysterec-
tomy, and the patient had an uneventful postoperative course.
Conclusion: The efficacy and complications of UAE as a therapeutic modality for the conservative management
of invasive placentation in the first trimester of pregnancy are not clear, as this is the first report of its kind.
However, although UAE had failed in this case, it may still be a useful procedure as a prophylactic measure
before surgical intervention, and hysterectomy can also be performed for better control of operative hemor-
rhage. [Taiwanese J Obstet Gynecol 2006;45(2):150–154]
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To our knowledge, conservative management of pla-
centa percreta in the first trimester using uterine artery
embolization (UAE) in order to preserve fertility has not
been previously reported. We describe our clinical expe-
rience with UAE in the management of placenta previa
percreta in such an early stage of pregnancy.
Case Report
A 36-year-old woman, gravida 3, para 1, was referred
for ultrasonographic evaluation because of suspected
molar pregnancy due to persistent vaginal spotting
during early pregnancy. The patient’s obstetric history
was significant for one previous lower segment cesarean
section and uterine curettage for abortion. Surgical
correction of a complete uterine septum had been per-
formed during her previous cesarean delivery.
Grayscale transvaginal ultrasonography at 9 weeks
of gestation revealed an intrauterine viable embryo
with a crown–rump length of 27 mm. The -human
chorionic gonadotropin (-hCG) level was 89,110
mIU/mL. The bulky placental tissue encircling the fetus
was located within the whole mid-lower portion of the
uterus and covered the internal os of the cervix. A Grade
3+ lacunar flow pattern as described by Finberg and
Williams [3] with multiple bizarre and large irregular
sonolucent spaces were observed (Figure 1A). CDU
(Voluson 730 Expert, GE Medical Systems, Kretztechnik,
Zipf, Austria) revealed extensive turbulent lacunar blood
flow perfusing throughout the whole surrounding utero-
placental tissues and fetus (Figure 1B). Pulsed Doppler
interrogation of the intraparenchymal echolucent spaces
and supplying high-pressure myometrial vasculature
yielded a pulsatile high-velocity (15–30 cm/sec) venous
flow within the lacunar spaces, and low-resistance (resis-
tance index0.34) arterial blood flow, respectively.
After appropriate counseling, the patient opted 
for conservative treatment with UAE to preserve the
uterus. Informed consent for UAE was obtained from
the patient. Superselective transarterial embolization
of the bilateral uterine arteries and branches, and
other supplying parasitized vessels when necessary, was
achieved with a 4F RC 1 catheter (Cordis, Miami Lakes,
FL, USA) using 600–1,000m polyvinyl alcohol (PVA)
particles (Ivalon, Heyer Schulte, CA, USA) and pledgets 
of absorbable gelatin sponges (Gelfoam, Johnson &
Johnson, Skipton, UK) of varying sizes. Markedly
decreased uteroplacental blood flow was recognized
immediately on postembolization angiographic study
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Figure 1. (A) Grayscale ultrasonographic evaluation at 9
weeks’ gestation reveals multiple bizarre and large irregular
sonolucent spaces within the placenta parenchyma. The bulky
placental tissue encircling the fetus is located within the whole
mid-lower portion of the uterus and covers the internal os of
the cervix. (B) Color Doppler ultrasonography (CDU) shows
extensive lacunar blood flow perfusing throughout the whole
surrounding uteroplacental tissues and fetus. (C) On the 2nd
day of follow-up, CDU shows markedly decreased uteropla-
cental hypervascularity in the region of interest after UAE.
Bbladder; L lacunar space; Pplacenta.
(Figure 2). On the 2nd day of follow-up, CDU was per-
formed, which revealed a satisfactory devascularization
pattern in the region of interest (Figure 1C). The cardiac
motion of the fetus was not detected. A heterogeneous
patchy echogenic pattern consistent with ischemic
change of uteroplacental tissue was noted. Subsequent
methotrexate 75 mg (50 mg/m2) was administered intra-
muscularly once a week for 2 consecutive weeks as
adjuvant therapy. Serum -hCG level dropped to
2,224 mIU/mL and remained at about this level 
thereafter.
Unfortunately, follow-up CDU showed a gradually
increased uteroplacental vascularity due to recanaliza-
tion and collateral circulation 3 weeks after the first
UAE. After counseling, the patient decided to receive 
a second UAE procedure. This time, the interventional
radiologists again chose to use PVA particles of various
sizes, ranging from 600 to 1,000m, to provide a more
definite devascularization in the targeted region of
increased vascularity. Two weeks later, however, serial
follow-up CDU revealed an unsatisfactory vessel-
occluding effect caused by extensive pelvic collateral
circulation. Finally, we deemed a hysterectomy to be 
a necessary definite therapy of choice because we were
concerned about the inadequate devascularization
and unpredictable outcome of invasive placentation.
The total estimated blood loss was 4,000 mL. The
major blood loss was caused by a difficult hysterec-
tomy during dissection of the densely adherent bladder–
lower uterine segment boundary zone, and prominent
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Figure 2. (A) Diagnostic angiography of the right internal iliac artery and its uterine branches. (B) Left internal iliac artery and
its uterine branches. Extensive uteroplacental hypervascularity with numerous tortuous branching new blood vessels is noted before
embolization. (C) Postembolization angiography shows the almost complete occlusion of the supplying vessels in the targeted
region of interest. (D) Repeated angiography shows markedly increased uteroplacental vascularity 3 weeks after the first UAE.
collateral circulation persisted even after the UAE pro-
cedure. The patient had an uneventful postoperative
course. Histopathologic examination of the resected
hysterectomy specimen revealed placental villi invad-
ing the outermost layer of the lower segment of the
myometrium. In addition, histologic examination found
necrotic villi with placental infarct in combination with
intervillous thrombosis.
Discussion
A number of risk factors including placenta previa, a
history of cesarean section, uterine curettage and
metroplasty for septate uterus, and advanced mater-
nal age have been identified in this case. We agree that
placenta percreta is caused by a combination of risk
factors, and it is unlikely that its occurrence can be
attributed to any single risk factor [4]. The etiology
may be due to increased interaction between the tro-
phoblasts and the inadequate deciduas or even myo-
metriums. Placental implantation is, to a large extent,
controlled by a complex interplay between surface
molecules on trophoblasts and cells in the uterus.
Different cytokines, enzymes, receptors, and adhesion
molecules play an essential role. Therefore, a loss of 
balance between trophoblast invasion and maternal
decidual–myometrial defense barrier may result in pla-
centa accreta. We acknowledge that decidual defect is
a major contributing factor for the formation of pla-
centa accreta, however, decidua- or even myometrium-
and/or stroma-derived factors may cause differing
expression of trophoblast invasion factors, thus result-
ing in the formation of placenta accreta [5,6].
Clinical implications of reproductive outcomes in
women with various mullerian anomalies include infer-
tility, early pregnancy loss, a high incidence of obstetric
complications such as preterm delivery, premature rup-
ture of membranes, malpresentation, and fetal growth
restriction [7]. In a literature review of 51 cases with rudi-
mentary horn pregnancies, seven were associated with
placenta accreta [8]. However, the causal relationship
between other forms of mullerian anomalies and pla-
centa accreta has not been reported previously. Further
studies are needed to address this issue.
Earlier antenatal identification of abnormal pla-
centation has a positive impact on the peripartum clin-
ical management of at-risk obstetric patients. Manage-
ment options include operative strategy to terminate
the pregnancy before fetal viability in affected patients
with extensive hypervascularization highly suggestive of
severely invasive placentation. Prophylactic preoperative
internal iliac artery embolization before hysterectomy
can be offered in an attempt to reduce intraoperative
blood loss [9].
The UAE approach has been described for the con-
servative management of placenta percreta left in situ
after delivery in some cases with variable outcomes
[10–13]. However, there is little prospective experience
in the conservative treatment of placenta percreta 
during the first trimester in order to preserve uterine
fertility. Therefore, such an approach is still of an exper-
imental and investigational nature [14]. After the uter-
ine arteries and other supplying parasitized collateral
blood vessels are occluded by UAE, most blood stops
flowing in the uteroplacental arteries and veins, adher-
ent placental tissue does not survive this period of
uterine ischemia and trophoblasts degenerate and die.
In the literature, the majority of retained placenta in
ectopic pregnancy such as cervical pregnancy, cesarean
scar pregnancy, and interstitial pregnancy would usu-
ally take 3 months to achieve complete resolution
[15–17]. However, conservative management of pla-
centa percreta with placenta left in situ after delivery 
in the third trimester would usually take much longer
(3–6 months) to promote involution and shedding 
of the adherent placenta following UAE [12,13].
Therefore, the 2–6 week duration of occlusion using
absorbable Gelfoam particles is insufficient for a satis-
factory vessel-occluding effect. In this case, failure to
achieve adequate devascularization with PVA particles
was caused by extensive pelvic collateral circulation.
Therefore, permanent metal coil embolization of the
internal iliac arteries may be necessary to provide more
definitive devascularization with potential complica-
tions of embolization of nontargeted pelvic organs
such as the ovaries, buttocks, and bladder. Further
studies are necessary to validate our findings that UAE
may be inadequate as an alternative to hysterectomy
for those patients with severe invasive placentation
who wish to preserve their fertility or when surgery 
is contraindicated. Although complication rates and
disadvantages associated with UAE are low [18], in
rare cases, they can include prolonged follow-up and
delayed hemorrhagic complications, thus increasing
rates of hospital readmission with surgical reinterven-
tion [11]. Moreover, reproductive capacity may be
altered by placental chronic retention and further
pregnancies may be complicated by recurrent placenta
accreta [5,19].
In conclusion, from our experience, we believe that
obstetric patients at risk for placenta percreta can be
identified successfully during early pregnancy by the
complementary combination of grayscale US and
CDU [20,21]. It is strongly recommended that women
who wish to undergo UAE for uterus preservation
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undergo a thorough evaluation by an obstetrician to
help facilitate optimal collaboration with interventional
radiologists and to ensure the appropriateness of this
investigational therapy, taking into account the repro-
ductive wishes of the patient [18]. The efficacy and
complications of UAE as a therapeutic modality for the
conservative management of severely invasive placenta-
tion in the first trimester of pregnancy are not clear, as
this is the first report of its kind. However, although
UAE failed in this case, it may still be a useful prophy-
lactic measure before surgical intervention, and hys-
terectomy can also be performed for better control of
operative hemorrhage.
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